Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
1200
Trial Sponsor
Clinical Trial Start Date
November 14, 2018
0Primary Completion Date
March 15, 2020
0Study Completion Date
March 15, 2020
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Dietary Supplement0
Intervention Name
Myoinositol0
Placebo (for myoinositol)0
Interventional Trial Phase
Not Applicable0
Official Name
Myoinositol Supplementation, Insulin Resistance and Fetal Sonographic Parameters in Gestational Diabetes, Diet Treated: a Prospective, Randomized, Placebo-controlled Study0
Last Updated
March 24, 2020
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Double0
Masked Party
Care Provider0
Participant0
Study summary
The aim of this study is to verify the beneficial effects on insulin resistance and fetal sonographic parameters of a diet supplementation of myoinositol taken during the third trimester by pregnant women affected by gestational diabetes. Participants should be randomly allocated to take either myoinositol or placebo twice/day for 8 weeks. The effect of myoinositol will be checked in blood samples (insulinemia and Homeostasis Model Assessment - Insulin Resistance "HOMA-IR") and in fetal sonographic parameters after 4 and 8 weeks from the beginning of the nutritional supplementation.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
